The first quarter 2026 financial results and business update will be discussed during a conference call and webcast presentation today at 2:30 PM CET/8:30 AM ET. A webcast of the live call may be ...

Early GO decision reached in CAPTIVATE in March 2026 based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...

In a double-blind, placebo-controlled phase 2 randomized clinical trial, vemircopan did not meet the predefined efficacy ...

Investigational treatment improves outcomes without complete complement blockade ...

IIIT Dharwad’s CoE aims to bring quantum access, training, and industry links to tier-2 regions within months.

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient popu ...

Understanding drug resistance is crucial. Quantum modeling offers insights into molecular interactions, enhancing drug ...

It was mainly African Americans, and especially free Blacks, who manned the batteaux that carried crops down Virginia rivers to Richmond markets. A number of Rockbridge free Blacks were boatmen on the ...

Patterns of molecular activity in the blood may hold clues not only to how fit someone is, but also to the biological ...